Table 2.
Standardised rate ratio for incidence and mortality of the leading cancer sites among the rural vs. urban population, Varanasi, India, 2017–2019. (N = 6721)
| Cancer sites | Incidence rate (AAR per 100,000) |
Standardised Rate Ratio (95% Confidence Interval) |
||||||
|---|---|---|---|---|---|---|---|---|
| Rural | Urban | Male | Female | |||||
| Male | Female | Male | Female | Incidence | Mortality | Incidence | Mortality | |
| All sites | 60.8 | 59.0 | 81.7 | 63.2 |
0.74 (0.73–0.75) * |
0.79 (0.77–0.80) * |
0.93 (0.92–0.95) * |
1.18 (1.16–1.21) * |
|
Mouth (C03-06) |
15.0 | 2.9 | 24.3 | 2.3 |
0.62 (0.60–0.63) * |
0.74 (0.72–0.77) * |
1.25 (1.16–1.35) * |
1.53 (1.40–1.67) * |
|
Tongue (C01-02) |
3.9 | 1.4 | 7.1 | 1.5 |
0.56 (0.53–0.59) * |
0.60 (0.56–0.64) * |
0.97 (0.88–1.06) |
1.02 (0.91–1.15) |
|
Breast (C50) |
0.1 | 12.7 | - | 15.9 | - | - |
0.80 (0.77–0.83) * |
1.13 (1.08–1.19) * |
|
Cervical (C53) |
- | 10.3 | - | 6.9 | - | - |
1.49 (1.43–1.55) * |
1.74 (1.65–1.83) * |
|
Ovary (C56) |
- | 3.2 | - | 4.5 | - | - |
0.70 (0.66–0.75) * |
0.83 (0.76–0.91) * |
| Corpus uteri (C54) | - | 0.6 | - | 1.9 | - | - |
0.32 (0.28–0.36) * |
0.09 (0.07–0.12) * |
|
Prostate (C61) |
2.8 | - | 4.1 | - |
0.67 (0.63–0.71) * |
0.96 (0.90–1.03) |
- | - |
|
Colon (C18) |
0.6 | 0.3 | 1.7 | 0.9 |
0.35 (0.31–0.39) * |
0.46 (0.39–0.53) * |
0.28 (0.23–0.33) * |
0.42 (0.34–0.52) * |
| Oesophagus (C15) | 1.3 | 0.7 | 3.1 | 1.3 |
0.41 (0.38–0.45) * |
0.41 (0.37–0.44) * |
0.51 (0.45–0.58) * |
0.66 (0.57–0.77) * |
|
Liver (C22) |
4.1 | 3.0 | 2.7 | 1.9 |
1.53 (1.44–1.63) * |
1.64 (1.53–1.75) * |
1.55 (1.43–1.67) * |
1.82 (1.68–1.97) * |
| Gallbladder (C23-24) | 3.5 | 8.7 | 3.2 | 6.2 |
1.10 (1.04–1.17) * |
1.45 (1.35–1.55) * |
1.42 (1.35–1.48) * |
1.52 (1.45–1.60) * |
*Significant difference